Hankosky, PhD, senior director of Cardiometabolic Health, Health Economics and Outcomes Research at Eli Lilly & Company, and corresponding author of this study, confirmed for Medical News Today that the participants were taking Mounjaro as an off-label treatment for weight management at the discretion of their prescribing physician. During their study, researchers also reported that about 32% of participants who started tirzepatide had class 3 obesity with a BMI of 40 kg/m 2 or more
A true partner in innovation." Mark Stephens, Product Developer, USA "Professional, scientific, and efficient
In each treatment session, approximately 24% of the adipocytes within a targeted area undergo apoptosis, leading to a reduction in local fat stores
Lost 53 pounds
The highest amount of oxidative stress is in your brain, so the brain requires the highest amount of antioxidants